Results

Total Results: 48 records

Showing results for "consideration".

  1. cds.ahrq.gov/cdsconnect/artifact/recommendation-8-naloxone-consideration
    September 27, 2018 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  2. cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
    January 01, 2024 - As part of the Patient Population Under Consideration section of the full recommendation statement, … Inclusions (from the Patient Population Under Consideration section) “Race = African American … Inclusions (from the Patient Population Under Consideration section) “Ethnicity = Hispanic … Although the racial/ethnic groups identified in the Patient Population Under Consideration section of … Add explanation “No symptoms of diabetes” The Patient Population Under Consideration section of the
  3. cds.ahrq.gov/sites/default/files/cds/artifact/686/Clostridium%20difficile%20(C.diff)%20Infection%20Treatment%20Pathway_updated%20March%202019.pdf
    January 01, 1970 - fulminant CDI NO, First CDI Episode YES, Recurrent CDI Episode Consult infectious disease (ID) for consideration
  4. cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
    January 01, 2024 - Depending on the availability and comprehensiveness of patient data sources, consideration of other … As part of the Patient Population Under Consideration section of the full recommendation statement, … Inclusions (from the Patient Population Under Consideration section) “Race = African American … Inclusions (from the Patient Population Under Consideration section) “Race = American Indian … Inclusions (from the Patient Population Under Consideration section) “Ethnicity = Hispanic or
  5. cds.ahrq.gov/sites/default/files/workgroups/246/jul-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Given the testing timeline, the implementation team decided to include this consideration in the recommendation … Clinical Domains CAMH requested the WG’s feedback and experiences with numerous clinical domains under consideration … CDS warnings about high risk meds is a consideration.
  6. cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Discuss Remaining Repository Questions CAMH provided a brief overview of the metadata under current consideration
  7. cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
    January 01, 2016 - validate identified artifacts for potential CDS build out, and identify additional clinical resources for consideration … Sources TBD · Rules generated from CPGs · ASCVD – Yes/No · Determine 4 high risk groups for LLT consideration
  8. cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
    January 01, 2017 - other than cirrhosis, e.g. fatty liver disease, shouldn’t be automatically excluded from statin therapy consideration
  9. cds.ahrq.gov/sites/default/files/workgroups/241/jun-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Steps and Closing CAMH will provide an update on the pilot and discuss clinical domain areas under consideration
  10. cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
    July 23, 2024 - hospice care) ▪ Undergoing active cancer treatment since they have unique needs that require special consideration
  11. cds.ahrq.gov/sites/default/files/workgroups/251/aug-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 08/09/2017 Time 1:30 – 2:45 PM EST AGENDA · Welcome and Review of Agenda · Demonstration of the CDS Connect Repository · Demonstration of the CDS Connect Authoring Tool · Next Steps and Close SUMMARY Welcome CAMH welcomed the attendees to the August…
  12. cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Presentation.pdf
    January 01, 2022 - March 2022 CDS Connect Work Group Presentation March 2022 CDS Connect Work Group Call Agenda Schedule Topic 3:00 - 3:02 Roll Call, Michelle Lenox (MITRE) 3:02 - 3:05 Review of the Agenda, Maria Michaels (CDC) 3:05 - 3:50 CDS Artifact Versioning (MITRE/CDC/Alphora) 3:50 - 3:55 What's New with CDS Connect (MITR…
  13. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - recommended preventive services based on that patient’s individual health history and risk factors.7 Consideration … Depending on the availability and comprehensiveness of patient data sources, consideration of other … patient preferences and effective patient decision making, facilitating patient action, and ensuring consideration
  14. cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
    January 01, 2024 - recommended preventive services based on that patient’s individual health history and risk factors.3 Consideration … Depending on the availability and comprehensiveness of patient data sources, consideration of other … With Cardiovascular Risk Factors: Behavioral Counseling Interventions.2 The Patient Population Under Consideration … been shown to produce software that is more robust and to contain fewer bugs because it requires consideration … interventions to promote a healthy diet and physical activity.”2 Within the Patient Population Under Consideration
  15. cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Summary.pdf
    January 01, 2022 - March 2022 CDS Connect Work Group Summary Clinical Decision Support (CDS) Connect Work Group (WG) Meeting Summary March 17, 2022 3:00 – 4:00 pm ET Attendees: 37 people, including 4 phone dial-ins Organization Attendees AHRQ Sponsors Mario Teran; Roland Gamache; Steve Bernstein (3) WG Members Andrey…
  16. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - recommended preventive services based on that patient’s individual health history and risk factors.7 Consideration … Depending on the availability and comprehensiveness of patient data sources, consideration of other
  17. cds.ahrq.gov/sites/default/files/workgroups/34806/CDS_Connect_WG_October_2021_Summary.pdf
    January 01, 2021 - The WG also recommended the following “should Have,” second-tier consideration, which MITRE has also
  18. cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2022.pdf
    January 01, 2022 - This work is under consideration with AHRQ to continue with any future CDS Connect projects. 4.2 Simplified … Patient-Facing CDS Intervention No Yes Yes Yes 4 Occupational Factors Impacting Diabetes is under consideration … The WG has engaged throughout key project phases, from consideration of high-level desired outcomes … • Tracking stakeholder recommendations for consideration in future sprints.
  19. cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
    January 01, 2020 - The team’s criteria for considering updates included consideration of relevant research evidence, metadata … Baseline 10- Year ASCVD Risk No Yes Yes No 10 Occupational Factors Impacting Diabetes is under consideration … The WG has engaged throughout key project phases, from consideration of high-level desired outcomes … sustainer organizations, Federal partners, and grantees) • Tracking stakeholder recommendations for consideration
  20. cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
    November 11, 2019 - are often simplistic in nature or do not take the specific patient and pharmacological contexts into consideration

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: